AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...

The highest dose of AstraZeneca’s small molecule halved levels of a type of “bad” cholesterol after 12 weeks, hitting the ...

LDL cholesterol goals, cardiovascular risk assessment, therapeutic goals, and pharmacologic treatment options are discussed for both primary and secondary prevention of cardiovascular disease.

Elevated cholesterol is a major risk factor for atherosclerosis and coronary heart disease, and its control remains poor. Diet and exercise may not achieve LDL-C goals, particularly in high-risk ...

Cholesterol is a waxy fat produced by the liver and found in various foods. However, high cholesterol can affect many people ...

The largest analysis to date on cholesterol-lowering treatments has found that people with blocked arteries or who are at ...

A lipid profile typically shows results for four different types of lipids: The goal is to have a proper balance of these numbers. Generally speaking, LDL and total cholesterol should be low ...

“is associated with more effective LDL [cholesterol] goal achievement and is responsible for significant incremental reductions in cardiovascular health problems and deaths.” Nearly 94 million ...

The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...

Statins are very cheap and highly effective cholesterol-lowering drugs -- but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another ...

In clinical practice, a combination of drugs is often used to treat patients with dyslipidemia who are not achieving their treatment goals. Ezetimibe reduces LDL cholesterol levels, and niacin ...